2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.

      Oral Diseases
      Azacitidine, analogs & derivatives, pharmacology, Carcinogenesis, pathology, Carcinoma, Squamous Cell, Cell Adhesion, genetics, Cell Culture Techniques, Cell Line, Tumor, Cell Movement, Cells, Cultured, DNA Modification Methylases, antagonists & inhibitors, Down-Regulation, Gene Expression Regulation, Neoplastic, Gene Knockdown Techniques, Humans, Insulin Receptor Substrate Proteins, physiology, Keratinocytes, drug effects, MicroRNAs, analysis, Mouth Neoplasms, Neoplasm Invasiveness, Neoplasm Staging, Oncogene Protein v-akt, RNA, Small Interfering, TOR Serine-Threonine Kinases

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          MicroRNAs play important roles in carcinogenesis. A preliminary screening study suggested that down-regulation of miR-370 occurs in oral squamous cell carcinoma (OSCC) tissue. Insulin receptor substratre-1 (IRS-1) is the substrate of insulin-like growth factor receptor (IGFR), which modulates AKT/mTOR activation in malignancies. The relationship between miR-370 and IRS-1, and their functional roles in OSCC pathogenesis are unclear. Primary OSCC specimens were examined for miR-370 expression. Exogenous expression of miR-370 was established using both stable subclones and transient expression, and these were used to gain insights into miR-370's functions in OSCC cells. Knockdown of miR-370 and IRS-1 was also carried out in OSCC cells using a small interference oligonucleotide approach. Squamous cell carcinoma tissues with perineural invasion had lowered miR-370 expression compared with contrasting OSCC. OSCC cells also exhibited lower miR-370 expression than normal oral keratinocytes, and this can be reversed by treatment with 5-aza-2'-deoxycytidine. Exogenous miR-370 expression decreases the migration and anchorage-independent growth of OSCC cells, which implies a suppressor role for miR-370. The enhancement of anchorage-independent growth of OSCC cells through miR-370 inhibiting can be reduced by knockdown of IRS-1 expression. This study concludes that miR-370 is able to target IRS-1 for oral tumorigenesis. © 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

          Related collections

          Author and article information

          Comments

          Comment on this article